| Product Code: ETC12588430 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Lung Cancer Therapeutic Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Lung Cancer Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Lung Cancer Therapeutic Market - Industry Life Cycle |
3.4 Canada Lung Cancer Therapeutic Market - Porter's Five Forces |
3.5 Canada Lung Cancer Therapeutic Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Canada Lung Cancer Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Canada Lung Cancer Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Lung Cancer Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of lung cancer in Canada |
4.2.2 Technological advancements in lung cancer therapeutics |
4.2.3 Growing investments in research and development for lung cancer treatments |
4.3 Market Restraints |
4.3.1 High cost of lung cancer therapies |
4.3.2 Stringent regulatory requirements for approval of new treatments |
4.3.3 Limited accessibility to advanced lung cancer treatments in certain regions of Canada |
5 Canada Lung Cancer Therapeutic Market Trends |
6 Canada Lung Cancer Therapeutic Market, By Types |
6.1 Canada Lung Cancer Therapeutic Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.4 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.6 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.1.7 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2 Canada Lung Cancer Therapeutic Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Kinase Inhibitors, 2021 - 2031F |
6.2.3 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Platinum-based Drugs, 2021 - 2031F |
6.2.4 Canada Lung Cancer Therapeutic Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021 - 2031F |
6.2.5 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.3 Canada Lung Cancer Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Canada Lung Cancer Therapeutic Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
7 Canada Lung Cancer Therapeutic Market Import-Export Trade Statistics |
7.1 Canada Lung Cancer Therapeutic Market Export to Major Countries |
7.2 Canada Lung Cancer Therapeutic Market Imports from Major Countries |
8 Canada Lung Cancer Therapeutic Market Key Performance Indicators |
8.1 Survival rates of lung cancer patients |
8.2 Adoption rate of innovative lung cancer therapies |
8.3 Number of clinical trials for new lung cancer treatments in Canada |
9 Canada Lung Cancer Therapeutic Market - Opportunity Assessment |
9.1 Canada Lung Cancer Therapeutic Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Canada Lung Cancer Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Canada Lung Cancer Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Lung Cancer Therapeutic Market - Competitive Landscape |
10.1 Canada Lung Cancer Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Canada Lung Cancer Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here